MedPath

Exercise for Fighting Oncology Repercussions After Treatment

Not Applicable
Not yet recruiting
Conditions
Neoplasms
Interventions
Behavioral: Nordic Walking
Behavioral: Aquatic Exercise
Behavioral: Functional Exercise Training
Registration Number
NCT05980325
Lead Sponsor
Universitat Pompeu Fabra
Brief Summary

Cancer survival rates are currently on the verge of 70% at 5 years since diagnosis. Recent improvements in main cancer therapies including chemotherapy, radiotherapy, surgery and immunotherapy as well as developments of new biological therapies have significantly improved survival rates but unfortunately, cancer-related side effects continue to affect many patients even years after completion of main treatments. Exercise has been shown to not only ameliorate cancer-related effects before, during and after treatment but also improve disease-free and overall survival rates by decreasing risk factors associated with cancer risk and improving resilience to treatment. In this non-randomised, three-arm study, we aim to assess the effects of three forms of exercise (i.e: Nordic Walking, Aquatic Exercise and Functional Exercise) on physical performance, cancer-related fatigue, health-related quality of life and cancer-specific symptoms in a wide range of cancer survivors.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
45
Inclusion Criteria
  • Adults diagnosed with cancer
  • Completion of any cancer therapy in the previous 3 months with the exception of hormonal therapy
  • Patients living within the Maresme Area
  • No contraindications for exercise (oncology clearance or Physical Activity Readiness Questionnaire negative)
Exclusion Criteria
  • Patients with any neurologic, cognitive or musculoskeletal impairments that prevent them to engage in any assessment test or exercise modality.
  • Patients with unstable cardiac, respiratory or metabolic diseases
  • Unable to speak or read Catalan or Spanish

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Nordic WalkingNordic WalkingPatients in this arm will be assigned to a 12-week exercise intervention twice weekly based on Nordic Walking (NW). The intervention will be structured as follows: i) 10 min warm-up, ii) 40 min NW with muscle strengthening exercises interspersed in between and iii) 10 min cool-down. Intensity will be monitored with a heart rate monitor (when available) and/or Borg Scale to reach a moderate intensity for the first 6 weeks (4 - 6 or 55-65% HR reserve) to a moderate-to-high intensity the following weeks (7 - 8 or 65-75% HR reserve).
Aquatic ExerciseAquatic ExercisePatients in this group will be assigned to a 12-week, twice weekly water-based exercise programme to be conducted at a chest-high swimming pool kept around 30 to 32 degrees Celsius. Each session will be structured as previous: i) 10 min warm up; ii) 40 min of combined endurance and strength exercise training and iii) 10 min cool down. Intensity will be monitored using the Borg Scale to be moderate during the first 6 weeks (4 - 6) and moderate-to-high the following 6 weeks (7-8).
Functional Exercise TrainingFunctional Exercise TrainingIn this group, patients will participate in a traditional, circuit-based exercise training at a fitness facility twice daily during 12 weeks. Each session will consist of: i) 10 min warm up; ii) 40 min of combined resistance and endurance training using a circuit-based structure and iii) 10 min cool-down. Intensity will be monitored with a HR monitor (when available) and/or Borg Scale to reach a moderate intensity for the first 6 weeks (4 - 6 or 55-65% HR reserve) and will progress to moderate-to-high over the following weeks (7-8 or 65-75% HR reserve).
Primary Outcome Measures
NameTimeMethod
Health-Related Quality of Life12 weeks from baseline

HRQoL measured with the EORTC Quality of Life C30 questionnaire

Secondary Outcome Measures
NameTimeMethod
Estimated one-repetition maximum12 weeks from baseline

Estimated maximal muscle strength using a linear Encoder for two main muscle groups: i) chest and ii) quads

Lower limb muscle endurance12 weeks from baseline

Lower limb muscle endurance measured as the maximum number of sit-to-stand repetitions performed in 30 seconds

Functional capacity12 weeks from baseline

Walking distance covered during a self-pace 6 minute walk test

Cancer-related fatigue12 weeks from baseline

Cancer-related fatigue as measure with the Brief Fatigue Inventory

Cardiorespiratory fitness12 weeks from baseline

A steady state cardiopulmonary exercise testing with breath-by-breath analysis and lactate measurement to determine submaximal cardiorespiratory fitness

© Copyright 2025. All Rights Reserved by MedPath